A Phase II Study of Concurrent Radiation Therapy, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in the First-Line of Treatment of Patients With Glioblastoma Multiforme.
Phase of Trial: Phase II
Latest Information Update: 26 Nov 2014
At a glance
- Drugs Bevacizumab (Primary) ; Everolimus (Primary) ; Temozolomide
- Indications Glioblastoma
- Focus Therapeutic Use
- 06 Jun 2012 Planned end date changed from 1 Aug 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 02 May 2011 Planned end date changed from 1 Dec 2010 to 1 Aug 2011 as reported by ClinicalTrials.gov.
- 11 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.